Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 2Recruiting 2Active not recruiting 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Conditions

Xeroderma Pigmentosum 1Sebaceous Cell Tumor of Eyelid 1

Interventions

Cisplatin 352Oxaliplatin 262Capecitabine 258Radiotherapy 240Gemcitabine 223Docetaxel 223Carboplatin 223Cyclophosphamide 219Drug Therapy 218Paclitaxel 205apatinib 201Bevacizumab 195camrelizumab 190Fluorouracil 187sintilimab 133Blood Specimen Collection 125Irinotecan 124Dexamethasone 123Etoposide 119Radiosurgery 118toripalimab 117Surgical Procedures, Operative 115pembrolizumab 110Pemetrexed 108anlotinib 105S 1 (combination) 105Surveys and Questionnaires 101Leucovorin 101Nivolumab 98tislelizumab 96

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × OTHER × Longitudinal Studies × Clear all
NCT06080009 2024-02-23

Analysis of Molecular Biomarkers in Periocular Adnexal Tumours

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Phase NA Unknown
20 enrolled

Sebaceous Cell Tumor of Eyelid

NCT01123694 2010-05-14

Xeroderma Pigmentosum Patient Experiences

Henry Ford Health System

Unknown
15 enrolled

Xeroderma Pigmentosum

Data powered by HemOnc (CC BY 4.0) Colophon âš¡